Work

Novel antiangiogenic drugs, immune checkpoint inhibitors, and chemotherapy in patients with aNSCLC who have aggressive disease: A systematic review.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.e21120

Authors: Katherine B. Winfree, Claire Ainsworth, Annete Njue, Cliff Molife, Matthew Lyall, Min-Hua Jen, Marisa Bittoni, Anne Heyes, David Paul Carbone

Institutions: Eli Lilly (United States), RTI Health Solutions, The Ohio State University Wexner Medical Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890564690

Cites:

Cited by:

Related to: 10